Introduction
Inflammatory bowel diseases (IBD), including Crohn’s disease and ulcerative colitis, are chronic conditions that significantly impact quality of life, encompassing physical, emotional, and social dimensions. Coping strategies play a central role in adaptation to chronic illness and may influence the course of IBD. However, the relationship between coping and quality of life in patients with IBD remains incompletely understood.
Results & Findings
A total of 46 patients were included, with a predominance of females (71%), a median age of 38 (15–68) years, and a mean disease duration of 10.2 (1–29) years. Ulcerative colitis was slightly more prevalent (52.2%), and most patients were receiving biological therapy (79.4%). Moderate impairment in quality of life was observed, with median scores of 48 (0–67) in the intestinal domain, 23 (0–35) in the systemic domain, 57 (0–70) in the emotional domain, and 23 (0–35) in the social domain, indicating a greater impact on systemic aspects. Overall quality of life showed significant correlations with adaptive coping strategies, including active coping (p < 0.001), acceptance (p < 0.001), and positive reframing (p < 0.001), as well as an association with behavioral disengagement (p = 0.024). Domain-specific analysis revealed that the intestinal domain correlated with active coping (p = 0.001), acceptance (p < 0.001), positive reframing (p < 0.001), and adaptive coping (p = 0.039). The emotional domain was associated with active coping and acceptance (p < 0.001 for both), while the social domain correlated with active coping, acceptance, and positive reframing (p < 0.001), and showed a negative association with denial (p = 0.036). No differences in coping strategies were observed between disease types or disease duration.
Summary & Discussion
Despite widespread biologic therapy, patients with IBD show persistent impairment in quality of life, particularly in the systemic domain, indicating gaps beyond inflammatory control. Adaptive coping strategies were consistently associated with better outcomes, while denial correlated with poorer social well-being. The lack of association with disease type and duration suggests a greater influence of individual psychosocial factors over clinical variables.
Conclusion
Coping strategies are key determinants of quality of life in IBD, independent of traditional clinical factors. Incorporating coping assessment (e.g., Brief COPE) may improve risk stratification and support targeted psychosocial interventions, enhancing patient-centered outcomes.
References
G. R. Guyatt et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology, 1989.
Charles S. Carver. You want to measure coping but your protocol’s too long: consider the Brief COPE. International Journal of Behavioral Medicine, 1997.
EUROPEAN CROHN’S AND COLITIS ORGANISATION (ECCO). ECCO Guidelines on Inflammatory Bowel Disease. Vienna: ECCO, 2023. Disponível em: https://www.ecco-ibd.eu. Acesso em: 23 abr. 2026.
KAPLAN, Gilaad G.; NG, Siew C. Understanding and preventing the global increase of inflammatory bowel disease. Nature Reviews Gastroenterology & Hepatology, London, v. 14, n. 9, p. 497–506, 2017.